Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001
Symbol
BNTC on Nasdaq
Shares outstanding
35,393,481
Price per share
$11.84
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
31,662,101
Total reported value
$426,562,132
% of total 13F portfolios
0%
Share change
+8,450,248
Value change
+$113,780,072
Number of holders
71
Price from insider filings
$11.84
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUVRETTA CAPITAL MANAGEMENT, LLC 44% -12% $249,200,088 +$30,000,153 17,761,945 +14% SUVRETTA CAPITAL MANAGEMENT, LLC 07 Nov 2025
FRANKLIN RESOURCES INC 11% -29% $50,561,782 -$5,287,404 3,751,709 -9.5% Franklin Resources, Inc. 31 Dec 2025
JANUS HENDERSON GROUP PLC 10% -12% $44,484,293 -$292,158,468 3,382,836 -87% JANUS HENDERSON GROUP PLC 28 Nov 2025
RA CAPITAL MANAGEMENT, L.P. 5.5% $24,327,500 1,850,000 RA Capital Management, L.P. 07 Nov 2025
HBM Healthcare Investments (Cayman) Ltd. 4.5% $14,156,282 1,041,669 HBM Healthcare Investments (Cayman) Ltd. 31 Dec 2024
Nantahala Capital Management, LLC 4.4% -53% $14,111,462 1,038,371 0% Nantahala Capital Management, LLC 31 Mar 2025

As of 31 Dec 2025, 71 institutional investors reported holding 31,662,101 shares of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC). This represents 89% of the company’s total 35,393,481 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) together control 87% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SUVRETTA CAPITAL MANAGEMENT, LLC 33% 11,548,351 +17% 3.9% $155,556,288
JANUS HENDERSON GROUP PLC 8.2% 2,911,688 0% 0.02% $39,293,230
FRANKLIN RESOURCES INC 6.2% 2,197,305 -15% 0.01% $29,597,698
ADAGE CAPITAL PARTNERS GP, L.L.C. 6% 2,120,672 +7.5% 0.04% $28,565,452
RA CAPITAL MANAGEMENT, L.P. 5.2% 1,850,000 0.26% $24,919,500
VANGUARD GROUP INC 3.3% 1,174,758 +18% 0% $15,823,990
Nantahala Capital Management, LLC 2.9% 1,038,371 +24% 0.83% $13,986,857
BlackRock, Inc. 2.8% 992,347 +5% 0% $13,366,914
INFINITUM ASSET MANAGEMENT, LLC 2.5% 898,871 +80% 1.8% $12,107,792
Siren, L.L.C. 2.2% 775,000 0.31% $10,439,250
Alyeska Investment Group, L.P. 2.1% 750,000 0.03% $10,102,500
SILVERARC CAPITAL MANAGEMENT, LLC 2.1% 731,717 +165% 1.4% $9,856,228
Balyasny Asset Management L.P. 1.8% 651,558 0.02% $8,776,486
MILLENNIUM MANAGEMENT LLC 1.7% 613,160 0.01% $8,259,265
GEODE CAPITAL MANAGEMENT, LLC 1.3% 453,375 +3.4% 0% $6,108,556
Longaeva Partners L.P. 0.82% 290,000 +673% 0.46% $3,906,300
AWM Investment Company, Inc. 0.8% 282,977 +55% 0.37% $3,811,700
AMERIPRISE FINANCIAL INC 0.79% 280,727 +82% 0% $3,781,392
Schonfeld Strategic Advisors LLC 0.74% 262,205 +0.69% 0.02% $3,531,900
STATE STREET CORP 0.69% 245,051 +12% 0% $3,300,837
MYDA Advisors LLC 0.64% 225,000 +221% 0.85% $3,030,750
GOLDMAN SACHS GROUP INC 0.49% 174,041 -10% 0% $2,344,332
Simplify Asset Management Inc. 0.43% 151,163 +92% 0.03% $2,036,166
BURKEHILL GLOBAL MANAGEMENT, LP 0.42% 150,000 0.13% $2,020,500
NORTHERN TRUST CORP 0.36% 126,160 -3.4% 0% $1,699,375

Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 31,662,101 $426,562,132 +$113,780,072 $13.47 71
2025 Q3 23,155,291 $324,725,438 +$6,865,174 $14.03 55
2025 Q2 22,685,530 $265,306,276 +$16,737,178 $11.70 56
2025 Q1 21,243,183 $277,395,506 +$28,289,371 $13.01 37
2024 Q4 18,997,897 $240,166,135 +$64,576,294 $12.63 30
2024 Q3 13,715,023 $126,792,177 +$73,385,856 $9.19 25
2024 Q2 5,729,459 $39,940,820 +$31,087,038 $6.99 18
2024 Q1 1,270,837 $6,576,960 +$379,920 $5.25 13
2023 Q4 1,197,615 $3,880,452 -$214,565 $3.23 13
2023 Q3 1,267,947 $3,838,114 +$3,838,114 $3.02 11